Not applicableStudy completedNCT04456959What this trial is testingInO - A Retrospective Study of UK Patients With LeukaemiaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Pfizer 28
Testing effectiveness (Phase 2)Study completedNCT01627054What this trial is testingA Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia NCIC Clinical Trials Group 7
Early research (Phase 1)Study completedNCT00098423What this trial is testingTanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT01119794What this trial is testingOfatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After RituximabWho this might be right forLymphoma, Non-Hodgkins Brown University 10
Large-scale testing (Phase 3)Study completedNCT03476239What this trial is testingEfficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen 121
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Testing effectiveness (Phase 2)Study completedNCT02420912What this trial is testingNivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter TransformationWho this might be right forLoss of Chromosome 17pRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)UnknownNCT02782351What this trial is testingHumanized CAR-T Therapy for Treatment of B Cell MalignancyWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Kai Lin Xu; Jun Nian Zheng 50
Not applicableActive Not RecruitingNCT06125795What this trial is testingAssess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in SpainWho this might be right forChronic Lymphocytic Leukemia AbbVie 146
Early research (Phase 1)Ended earlyNCT04219319What this trial is testingLCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell LymphomaWho this might be right forCD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia) The First Affiliated Hospital with Nanjing Medical University 4
Testing effectiveness (Phase 2)Study completedNCT01520922What this trial is testingOfatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL)Leukaemia, Lymphocytic, Chronic Novartis Pharmaceuticals 99
Early research (Phase 1)Study completedNCT00735930What this trial is testingLenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forAnemiaChronic Lymphocytic LeukemiaProlymphocytic Leukemia+3 more National Cancer Institute (NCI) 39
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT00469820What this trial is testingVaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell TransplantWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Early research (Phase 1)Study completedNCT00691210What this trial is testingPhase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid MalignanciesWho this might be right forHodgkin's DiseaseNon-Hodgkin's Lymphoma Columbia University 40
Early research (Phase 1)Study completedNCT00058396What this trial is testingMonoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Not applicableStudy completedNCT00002485What this trial is testingDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more Children's Oncology Group 359
Early research (Phase 1)Ended earlyNCT01013818What this trial is testingHGS1029 in Subjects With Relapsed or Refractory Lymphoid MalignanciesWho this might be right forLymphoid Malignancies Human Genome Sciences Inc. 11